ILMNProducts•prnewswire•
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
Sentiment:Positive (70)
Summary
(NASDAQ:ILMN) Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease Following early access program, customers commend scale, high consistency, and easy sample to insights workflow Launch follows...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 3, 2025 by prnewswire